UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Severe Lymphocytosis in a Case of Diffuse Large B-Cell Lymphoma Treated by Ibrutinib

Turkish journal of haematology, 2021, Vol.38 (4), p.337-338

2021

Volltextzugriff (PDF)

LESS IS MORE: BETA-2 MICROGLOBULIN AS A FRAILTY MARKER IN COMMUNITY-DWELLING OLDER ADULTS

Geriatri, 2022-01

METE, Burak

2022

Volltextzugriff (PDF)

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study

Journal of cancer research and clinical oncology, 2023-02, Vol.149 (2), p.865-875

2023

Volltextzugriff (PDF)

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (8), p.4141-4148

2023

Volltextzugriff (PDF)

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Expert review of anticancer therapy, 2022-07, Vol.22 (7), p.773-780

2022

Volltextzugriff (PDF)

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Future oncology (London, England), 2022-07, Vol.18 (23), p.2573-2582

2022

Volltextzugriff (PDF)

Tumor Board Practice and Current Approach of Oncologists in Türkiye

Medical Science and Discovery, 2024-06, Vol.11 (6), p.189-195

2024

Volltextzugriff (PDF)

Brucella Endocarditis Presenting With Findings Resembling Vasculitis

Archives of rheumatology, 2015-01, Vol.30 (1), p.79-82

Yıldız, Fatih

2015

Volltextzugriff (PDF)

Gemcitabine-associated DRESS syndrome: A case report

Journal of oncology pharmacy practice, 2023-09, Vol.29 (6), p.1480-1483

2023

Volltextzugriff (PDF)

Capecitabine-related neurotoxicity presenting with agraphia

Journal of oncology pharmacy practice, 2023-04, Vol.29 (3), p.746-749

2023

Volltextzugriff (PDF)

Relationship between prognostic nutritional index and mortality in cancer patients treated with immunotherapy

Medicine science, 2023-12, Vol.12 (4), p.1134-9

2023

Volltextzugriff (PDF)

A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib

Genes, 2023-08, Vol.14 (8), p.1632

2023

Volltextzugriff (PDF)

Exploring the Impact of Cytogenetic Abnormalities on Treatment Responses and Survival Outcomes in Multiple Myeloma: A Single-Centre Experience of 13 Years of Follow-Up

Biomedicines, 2024-05, Vol.12 (5), p.1014

2024

Volltextzugriff (PDF)

Severe Lymphocytosis in a Case with Diffuse Large B Cell Lymphoma Treated by Ibrutinib

Turkish journal of haematology, 2021-08

2021

Volltextzugriff (PDF)

Sleep Quality Analysis in Metastatic Breast Cancer Patients Receiving Cyclin-Dependent Kinase 4-6 Inhibitor

Journal of oncological science, 2022, Vol.8 (3), p.113-118

2022

Volltextzugriff (PDF)

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.e6869-n/a

2024

Volltextzugriff (PDF)

Can the Pathological Response in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Treatment Be Predicted by the CEA/Albumin and CRP/Albumin Ratios?

Journal of clinical medicine, 2024-05, Vol.13 (10), p.2984

2024

Volltextzugriff (PDF)

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

BMC cancer, 2023-02, Vol.23 (1), p.136-136, Article 136

2023

Volltextzugriff (PDF)

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

BMC cancer, 2023-02, Vol.23 (1), p.192-192, Article 192

2023

Volltextzugriff (PDF)

Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel

Medical Science and Discovery, 2021-12, Vol.8 (12), p.740-744

2021

Volltextzugriff (PDF)

Vinorelbine-related tetraplegia due to severe peripheral neuropathy

Journal of oncology pharmacy practice, 2023-07, p.10781552231191469-10781552231191469

2023

Volltextzugriff (PDF)

Frailty is Independently Associated with Short Term Mortality and Hospitalization Due Heart Failure in the Elderly

Journal of the American College of Cardiology, 2013-10, Vol.62 (18), p.C50-C50

2013

Volltextzugriff (PDF)

Developments with 3D bioprinting for novel drug discovery

Expert opinion on drug discovery, 2018-12, Vol.13 (12), p.1115-1129

2018

Volltextzugriff (PDF)

Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy

American journal of hematology, 2023-02, Vol.98 (2), p.361-364

2023

Volltextzugriff (PDF)

Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan

Biomarkers in medicine, 2021-08, Vol.15 (11), p.851-859

2021

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Severe Lymphocytosis in a Case of Diffuse Large B-Cell Lymphoma Treated by Ibrutinib

LESS IS MORE: BETA-2 MICROGLOBULIN AS A FRAILTY MARKER IN COMMUNITY-DWELLING OLDER ADULTS

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Tumor Board Practice and Current Approach of Oncologists in Türkiye

Brucella Endocarditis Presenting With Findings Resembling Vasculitis

Gemcitabine-associated DRESS syndrome: A case report

Capecitabine-related neurotoxicity presenting with agraphia

Relationship between prognostic nutritional index and mortality in cancer patients treated with immunotherapy

A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib

Exploring the Impact of Cytogenetic Abnormalities on Treatment Responses and Survival Outcomes in Multiple Myeloma: A Single-Centre Experience of 13 Years of Follow-Up

Severe Lymphocytosis in a Case with Diffuse Large B Cell Lymphoma Treated by Ibrutinib

Sleep Quality Analysis in Metastatic Breast Cancer Patients Receiving Cyclin-Dependent Kinase 4-6 Inhibitor

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study

Can the Pathological Response in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Treatment Be Predicted by the CEA/Albumin and CRP/Albumin Ratios?

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel

Vinorelbine-related tetraplegia due to severe peripheral neuropathy

Frailty is Independently Associated with Short Term Mortality and Hospitalization Due Heart Failure in the Elderly

Developments with 3D bioprinting for novel drug discovery

Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy

Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan

Suchergebnisse filtern